Clinical Trials Logo
  1. Home
  2. Blood Donation
  3. NCT06101238

BLOODSAFE Ghana- Iron and Nutritional Counselling Strategy — UH3BLIS  

Blood Donation Clinical Trial

Official title:
BLOODSAFE- Implementation of Iron Supplementation and Nutritional Counselling Interventions to Improve Availability and Safety of Blood in Ghana-a Type I Pragmatic Effectiveness- Implementation Hybrid Trial

Clinical Trial Summary

A randomized trial will compare 6-months of low-dose (65mg elemental iron daily) among prospective blood donors who are deferred for low haemoglobin but have passed all of the other pre-screening requirements for blood donation to a group of donors who were deferred from donating and receive the current standard of care (nutrition counseling only). An automated full blood count (FBC) will also be done to identify any safety concerns. The randomized trial will evaluate effectiveness with the primary outcome of at least one successful donation during a 12-month follow-up period. Safety will be evaluated by tracking iron supplementation related adverse events (e.g., lower gastrointestinal) and acceptability (e.g., compliance to study prescribed regimen) with monthly phone calls. Participants will be followed for a total of 12 months from screening with follow up phone calls at 4 weekly intervals. All participants will receive nutrition counselling and haemoglobin will be evaluated at screening. Individuals with very low haemoglobin (<10g/dl in females and <11g/dl in males) will be identified by an automated FBC at screening and referred for proper medical care. Sample size will be 264 per group: this gives 80% power for detecting an odds ratio of 2.6. With 2 donors recruited at each donation event, this will require 264 donation events. This corresponds to 2.5 donation events per week for 2 years or 2 donation events per week for 2.5 years.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06101238
Study type Interventional
Source University of Minnesota
Contact Susan E Telke, MS
Phone (612) 590-2697
Email telke001@umn.edu
Status Recruiting
Phase N/A
Start date January 11, 2024
Completion date April 2026
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05791968 - Blood Donation Could Improve Insulin Sensitivity N/A
Recruiting NCT02281565 - Attitudes About Blood Donation N/A
Enrolling by invitation NCT04410458 - Recruit Blood Donors Via SMS During Epidemic of COVID-19 （Repeat Trial） N/A
Completed NCT04306055 - Blood Donor Recruitment During Epidemic of COVID-19 N/A
Active, not recruiting NCT01610635 - INTERVAL Study: To Determine Whether the Interval Between Blood Donations in England Can be Safely and Acceptably Decreased N/A
Enrolling by invitation NCT04431180 - Recruit Blood Donors Via SMS During Epidemic of COVID-19 #Second Repeat Trial# N/A
Recruiting NCT04484896 - Message Framing on Recruiting Rh-D Negative Blood Donors N/A
Active, not recruiting NCT05678647 - Sucrosomial Iron and Iron Sulphate to Blood Donors N/A
Completed NCT05319951 - Effect of Different Liquids Intake in Vasovagal Reaction After Whole Blood Donation N/A
Completed NCT05213130 - Blood Donation and Subjective Well-being N/A
Completed NCT00023023 - Study of Transfusion-Transmitted Infections
Enrolling by invitation NCT06138899 - Enhancing Blood Donation at Schools and Beyond in Malawi N/A
Completed NCT04370886 - Recruit Blood Donors Via SMS During Epidemic of COVID-19 N/A